14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $141.16 $183.01 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Nov 15, 2019 $2.93 $2.99 $2.73 $2.77 175 345
Nov 14, 2019 $2.95 $3.05 $2.83 $2.87 90 133
Nov 13, 2019 $2.88 $3.12 $2.88 $2.93 66 278
Nov 12, 2019 $3.23 $3.23 $3.03 $3.10 84 886
Nov 11, 2019 $3.23 $3.23 $3.08 $3.16 44 581
Nov 08, 2019 $2.94 $3.16 $2.89 $3.08 57 822
Nov 07, 2019 $3.01 $3.17 $2.88 $2.89 60 384
Nov 06, 2019 $3.28 $3.32 $2.96 $2.98 112 423
Nov 05, 2019 $3.18 $3.31 $3.15 $3.23 102 468
Nov 04, 2019 $3.01 $3.25 $2.95 $3.14 93 679
Nov 01, 2019 $3.04 $3.10 $2.95 $3.04 43 682
Oct 31, 2019 $2.88 $3.03 $2.88 $3.03 32 934
Oct 30, 2019 $3.01 $3.06 $2.85 $2.91 70 871
Oct 29, 2019 $3.00 $3.09 $2.99 $3.03 42 369
Oct 28, 2019 $2.88 $3.03 $2.79 $2.95 31 799
Oct 25, 2019 $2.85 $2.90 $2.80 $2.86 37 711
Oct 24, 2019 $2.98 $3.00 $2.81 $2.82 50 077
Oct 23, 2019 $3.00 $3.06 $2.83 $3.00 77 582
Oct 22, 2019 $2.93 $3.13 $2.93 $2.99 62 579
Oct 21, 2019 $3.01 $3.13 $2.81 $2.92 126 443
Oct 18, 2019 $3.14 $3.22 $3.03 $3.08 69 335
Oct 17, 2019 $3.25 $3.30 $3.07 $3.11 67 625
Oct 16, 2019 $3.13 $3.34 $3.12 $3.24 95 699
Oct 15, 2019 $3.13 $3.26 $2.92 $3.16 81 735
Oct 14, 2019 $3.07 $3.20 $2.91 $3.10 82 028
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT